Using SpliceAI to triage splice-altering variants in 7,220 individuals with rare conditions highlights limitations of the precomputed scores
Martin Geary, A. C.; Lecoquierre, F.; Walker, S.; Whiffin, N.; Dawes, R.
Show abstract
BackgroundSpliceAI is a deep learning algorithm that predicts whether genetic variants are likely to affect splicing. Precomputed spliceAI predictions for all theoretical SNVs and small indels were released in 2019, and are used by variant annotation tools such as VEP and dbNSFP to batch annotate large numbers of variants quickly. While the use of precomputed scores vastly reduces the computational cost of retrieving spliceAI predictions, several limitations to their utility have emerged, for which the impact on the prioritisation of likely splice-altering variants in cohort studies has not been established. MethodsWe identify annotation and liftover errors present in the precomputed SpliceAI scores by comparing the original gene annotation file with MANE v1.0 Select transcripts. To quantify the impact that these factors may have in variant prioritisation pipelines for diagnostic purposes, we re-analysed variants in 660 genes linked to neurodevelopmental disorders (NDD), identified in 7,221 participants with NDD from the Genomics England 100,000 Genomes Project (100kGP). ResultsWe find outdated gene annotations and liftover errors impact 8.34% of theoretical SNVs included in the SpliceAI precomputed scores, and affect accuracy of SpliceAI predictions in 34.98% of disease-associated panelApp green genes. In 7,221 Genomics England participants, re-running SpliceAI with optimised parameters results in an increase of 18.2% predicted splice-altering variants compared with variants identified using precomputed scores alone. These variants constitute a diagnostic increase of 11.7% versus the precomputed scores, assessed retrospectively using confirmed diagnoses in 100kGP. In addition we identify a new diagnostic candidate (chr10:129963548:CCGGTGAG:C) in a participant with Ataxia which would be missed by the precomputed scores. To mitigate issues with the precomputed scores we provide SpliceAI-splint- a command-line tool to allow users to identify variants within a VCF file whose potential splice-altering effects would be missed by the precomputed scores. ConclusionsWe find that although the precomputed scores continue to represent a useful resource in the annotation of variants in cohorts with genetic disorders, we find key limitations that can lead to their missing clinically relevant splice-altering variants, and provide a command-line tool to mitigate these issues.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Advanced variant classification framework reduces the false positive rate of predicted loss of function (pLoF) variants in population sequencing data 97%
- MRSD: a novel quantitative approach for assessing suitability of RNA-seq in the clinical investigation of mis-splicing in Mendelian disease 97%
- Extracting and calibrating evidence of variant pathogenicity from population biobank data 95%
Similar papers in this journal
- Informing Variant Assessment using Structured Evidence from Prior Classifications (PS1, PM5, and PVS1 Sequence Variant Interpretation Criteria) 96%
- Mapping RNA splicing variations in clinically-accessible and non-accessible tissues to facilitate Mendelian disease diagnosis using RNA-seq 95%
- Utility of genome sequencing and group-enrichment to support splice variant interpretation in Marfan syndrome 95%
Similar papers in this journal
- GeneBreaker: Variant simulation to improve the diagnosis of Mendelian rare genetic diseases 94%
- Phasing of de novo mutations using a scaled-up multiple amplicon long-read sequencing approach 94%
- 5’ splice site GC>GT variants differ from GT>GC variants in terms of their functionality and pathogenicity 94%
Similar papers in this journal
- A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project. 96%
- Recommendations for clinical interpretation of variants found in non-coding regions of the genome 95%
- Systematic analysis of genetic and phenotypic characteristics reveals antisense oligonucleotide therapy potential for one-third of neurodevelopmental disorders 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.